Experienced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections

Dr. Christopher B. Benton

Hematology Oncology | Oncology | Hematology
Rocky Mountain Cancer Centers Llp
1700 S Potomac St, 
Aurora, CO 
Offers Telehealth
Experienced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Rocky Mountain Cancer Centers Llp
1700 S Potomac St, 
Aurora, CO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Christopher Benton is a Hematologist Oncology specialist and an Oncologist in Aurora, Colorado. Dr. Benton is rated as an Experienced provider by MediFind in the treatment of Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Myeloproliferative Neoplasms (MPN), and Bone Marrow Aspiration.

His clinical research consists of co-authoring 44 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Oncology
Hematology
Licenses
Internal Medicine in TX
Hospital Affiliations
The Medical Center Of Aurora & South Hospital
Hca-Healthone Dba Swedish Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SelectHealth
  • HMO
  • POS
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

ROCKY MOUNTAIN CANCER CENTERS LLP
1700 S Potomac St, Aurora, CO 80012

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2, Randomized, Open-Label, Multicenter Study to Evaluate Safety and Efficacy of Single Agent Selinexor Versus Treatment of Physician's Choice in Patients With Previously Treated Myelofibrosis
A Phase 2, Randomized, Open-Label, Multicenter Study to Evaluate Safety and Efficacy of Single Agent Selinexor Versus Treatment of Physician's Choice in Patients With Previously Treated Myelofibrosis
Enrollment Status: Active_not_recruiting
Publish Date: October 03, 2025
Intervention Type: Drug, Other
Study Drug: Selinexor
Study Phase: Phase 2
A Phase 1/2 Open-Label Study of the Safety, Tolerability and Efficacy of the Selective Inhibitor of Nuclear Export (SINE) Compound Eltanexor (KPT-8602) in Patients With Newly Diagnosed and Relapsed/Refractory Cancer Indications
A Phase 1/2 Open-Label Study of the Safety, Tolerability and Efficacy of the Selective Inhibitor of Nuclear Export (SINE) Compound Eltanexor (KPT-8602) in Patients With Newly Diagnosed and Relapsed/Refractory Cancer Indications
Enrollment Status: Completed
Publish Date: March 19, 2025
Intervention Type: Drug
Study Drug: KPT-8602
Study Phase: Phase 1/Phase 2
A Phase IIa Study of BL-8040 in Combination With Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma
A Phase IIa Study of BL-8040 in Combination With Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma
Enrollment Status: Terminated
Publish Date: October 31, 2023
Intervention Type: Drug
Study Drugs: BL-8040 CD34-Positive Hematopoietic Cells, Nelarabine
Study Phase: Phase 2
View 2 Less Clinical Trials

44 Total Publications

Phase 1 first-in-human dose-expansion study of the oral SF3B1 modulator H3B‑8800 in lower-risk myelodysplastic syndrome.
Phase 1 first-in-human dose-expansion study of the oral SF3B1 modulator H3B‑8800 in lower-risk myelodysplastic syndrome.
Journal: Leukemia research
Published: January 21, 2025
Similar Doctors
Experienced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Sujatha Nallapareddy
Hematology Oncology | Hematology | Oncology
Experienced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Sujatha Nallapareddy
Hematology Oncology | Hematology | Oncology

Rocky Mountain Cancer Centers Llp

10103 Ridgegate Pkwy, G01, 
Lone Tree, CO 
 (11.0 miles away)
303-925-0700
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sujatha Nallapareddy is a Hematologist Oncology specialist and a Hematologist in Lone Tree, Colorado. Dr. Nallapareddy is rated as a Distinguished provider by MediFind in the treatment of Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Iron Deficiency Anemia.

Experienced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Mark A. Sitarik
Hematology Oncology | Hematology | Oncology
Experienced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Mark A. Sitarik
Hematology Oncology | Hematology | Oncology

Rocky Mountain Cancer Centers Llp

4715 Arapahoe Ave, 
Boulder, CO 
 (31.4 miles away)
303-385-2000
Experience:
43+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mark Sitarik is a Hematologist Oncology specialist and a Hematologist in Boulder, Colorado. Dr. Sitarik has been practicing medicine for over 43 years and is rated as a Distinguished provider by MediFind in the treatment of Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. His top areas of expertise are Heyde Syndrome, Von Willebrand Disease (VWD), Paget Disease of the Breast, and Breast Cancer.

Experienced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Austin I. Poole
Hematology Oncology | Radiation Oncology | Hematology
Experienced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Austin I. Poole
Hematology Oncology | Radiation Oncology | Hematology

Rocky Mountain Cancer Centers Llp

4715 Arapahoe Ave, 
Boulder, CO 
 (31.4 miles away)
303-385-2000
Languages Spoken:
English
See accepted insurances

Austin Poole is a Hematologist Oncology specialist and a Radiation Oncologist in Boulder, Colorado. Dr. Poole is rated as a Distinguished provider by MediFind in the treatment of Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. His top areas of expertise are Prostate Cancer, Colorectal Cancer, Familial Colorectal Cancer, and Familial Prostate Cancer.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Benton's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 54 Advanced Conditions
View All 150 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile